Elevated levels of GRP78 could be observed in CRC cell lines and CRC patient tissue, with inhibition of GRP78 evoking enhanced sensitivity of CRC cells to chemotherapeutic agents (148). This evidence concerns the gene HSPA5 and colorectal carcinoma.